Viridian Therapeutics Inc
XNAS: VRDN
Viridian Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-00...
Read More
28.77
0.34
(1.20%)
1.5M
XNAS Volume
XNAS 12 Nov, 2025 3:51 PM (EST)
Board Meeting
The next board meeting for Viridian Therapeutics Inc is on 19 Nov 2025 for the purpose of Jefferies Global Healthcare Conference
See details
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Viridian Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..